Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ADL.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 73.43 2.19 1.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -92.53 -4.13 55.35
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value -2.28 11.87 12.15
Cash 1417.80 -14.55 0.96
Capex 41.32 < 0.005 < 0.005
Free Cash Flow 864.00 0.14 0.01
Revenue -26.32 0.47 0.64
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 29.02 0.51 0.40
Operating Margin 1103.25 -4.11 0.34
ROA 3378.47 -0.04 < 0.005
ROE 3075.42 -0.13 < 0.005
ROIC 1943.74 -0.08 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ADL.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ADL.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ADL.DE is permitted for members.